Tech. Well said! We have been treated like A ste
Post# of 148158
(Total Views: 733)
Posted On: 08/08/2020 9:29:34 AM
Tech. Well said! We have been treated like
A step sister and will continue to be imo.
I think it’s still early to get a $30 plus buyout.
A licensing deal seems to be the most practical
And effective way to proceed. I agree this would
Open the door to other applications.
NP is trying to to put pressure on the fda.
My guess is we get advanced to p3 in m/m.
A real accomplishment but expectations are so
High and having been slow played for so long, this
Result is less exciting than it should be.
A BP partner gets us thru the forest.
GLTA
A step sister and will continue to be imo.
I think it’s still early to get a $30 plus buyout.
A licensing deal seems to be the most practical
And effective way to proceed. I agree this would
Open the door to other applications.
NP is trying to to put pressure on the fda.
My guess is we get advanced to p3 in m/m.
A real accomplishment but expectations are so
High and having been slow played for so long, this
Result is less exciting than it should be.
A BP partner gets us thru the forest.
GLTA
(2)
(1)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼